drugset / Trial / NCT05125978

Efficacy and Safety of Canadá Association in the Treatment of Chronic Pain

NCT05125978 ↗

Phase 2 Withdrawn EMS
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy and safety of Canadá association in the treatment of chronic pain

Timeline

Start
2026-09
Primary completion
2028-07
Completion
2028-07

Outcome

Outcome not reported

Stopped (Business): “Strategy review”

Drugs

EvaluationDrugModalityDoseRoute
Subject Canadá Unknown — Oral
Comparator Tramadol Other / unclassified — Oral
Comparator dipyrone Unknown — Oral

Indications